This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses.
Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH). The company has been a key supplier of PET imaging agents, prostate cancer detection tools, and injectable cancer drugs to VA hospitals and military treatment facilities. This contract supports the VA's diagnostic imaging services for veterans across multiple regions by providing products like PYLARIFY, FDG, and NEURACEQ. Sofie also holds several other significant federal contract vehicles with the VA and DHA for the ongoing supply of its specialized radiopharmaceuticals and related services.